Patent · US Active

Genetically modified mouse comprising a chimeric TIGIT

US11464876B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yang Bai · Beijing, CN
Rui Huang · Beijing, CN
Yanan Guo · Beijing, CN
Xiaofei Zhou · Beijing, CN
Meiling Zhang · Beijing, CN

Key dates

Filing date	May 31, 2019
Grant date	Oct 11, 2022
Priority date	—
Expiry date	May 31, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2517/02
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the genetically modified non-human animals that express a human or chimeric TIGIT (e.g., humanized TIGIT), and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.